128 related articles for article (PubMed ID: 17332092)
1. Primary cultures of embryonic chicken neurons for sensitive cell-based assay of botulinum neurotoxin: implications for therapeutic discovery.
Stahl AM; Ruthel G; Torres-Melendez E; Kenny TA; Panchal RG; Bavari S
J Biomol Screen; 2007 Apr; 12(3):370-7. PubMed ID: 17332092
[TBL] [Abstract][Full Text] [Related]
2. Development of cell-based assays to measure botulinum neurotoxin serotype A activity using cleavage-sensitive antibodies.
Nuss JE; Ruthel G; Tressler LE; Wanner LM; Torres-Melendez E; Hale ML; Bavari S
J Biomol Screen; 2010 Jan; 15(1):42-51. PubMed ID: 19965805
[TBL] [Abstract][Full Text] [Related]
3. A protein chip membrane-capture assay for botulinum neurotoxin activity.
Marconi S; Ferracci G; Berthomieu M; Kozaki S; Miquelis R; Boucraut J; Seagar M; Lévêque C
Toxicol Appl Pharmacol; 2008 Dec; 233(3):439-46. PubMed ID: 18845174
[TBL] [Abstract][Full Text] [Related]
4. Immuno-detection of cleaved SNAP-25 from differentiated mouse embryonic stem cells provides a sensitive assay for determination of botulinum A toxin and antitoxin potency.
Yadirgi G; Stickings P; Rajagopal S; Liu Y; Sesardic D
J Immunol Methods; 2017 Dec; 451():90-99. PubMed ID: 28943257
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic effectiveness of botulinum neurotoxin A: potent blockade of autonomic transmission by targeted cleavage of only the pertinent SNAP-25.
Lawrence GW; Ovsepian SV; Wang J; Aoki KR; Dolly JO
Neuropharmacology; 2013 Jul; 70():287-95. PubMed ID: 23485402
[TBL] [Abstract][Full Text] [Related]
6. Post-intoxication inhibition of botulinum neurotoxin serotype A within neurons by small-molecule, non-peptidic inhibitors.
Ruthel G; Burnett JC; Nuss JE; Wanner LM; Tressler LE; Torres-Melendez E; Sandwick SJ; Retterer CJ; Bavari S
Toxins (Basel); 2011 Mar; 3(3):207-17. PubMed ID: 22069707
[TBL] [Abstract][Full Text] [Related]
7. Botulinum neurotoxin A impairs neurotransmission following retrograde transynaptic transport.
Restani L; Novelli E; Bottari D; Leone P; Barone I; Galli-Resta L; Strettoi E; Caleo M
Traffic; 2012 Aug; 13(8):1083-9. PubMed ID: 22519601
[TBL] [Abstract][Full Text] [Related]
8. Mastoparan-7 rescues botulinum toxin-A poisoned neurons in a mouse spinal cord cell culture model.
Zhang P; Ray R; Singh BR; Ray P
Toxicon; 2013 Dec; 76():37-43. PubMed ID: 24047963
[TBL] [Abstract][Full Text] [Related]
9. A microscale neuron and Schwann cell coculture model for increasing detection sensitivity of botulinum neurotoxin type A.
Hong WS; Young EW; Tepp WH; Johnson EA; Beebe DJ
Toxicol Sci; 2013 Jul; 134(1):64-72. PubMed ID: 23564642
[TBL] [Abstract][Full Text] [Related]
10. A substrate sensor chip to assay the enzymatic activity of Botulinum neurotoxin A.
Lévêque C; Ferracci G; Maulet Y; Grand-Masson C; Blanchard MP; Seagar M; El Far O
Biosens Bioelectron; 2013 Nov; 49():276-81. PubMed ID: 23787358
[TBL] [Abstract][Full Text] [Related]
11. Assessment of ELISA as endpoint in neuronal cell-based assay for BoNT detection using hiPSC derived neurons.
Pellett S; Tepp WH; Johnson EA; Sesardic D
J Pharmacol Toxicol Methods; 2017 Nov; 88(Pt 1):1-6. PubMed ID: 28465161
[TBL] [Abstract][Full Text] [Related]
12. Interactions of a potent cyclic peptide inhibitor with the light chain of botulinum neurotoxin A: Insights from X-ray crystallography.
Kumaran D; Adler M; Levit M; Krebs M; Sweeney R; Swaminathan S
Bioorg Med Chem; 2015 Nov; 23(22):7264-73. PubMed ID: 26522088
[TBL] [Abstract][Full Text] [Related]
13. Botulinum neurotoxin type A: Actions beyond SNAP-25?
Matak I; Lacković Z
Toxicology; 2015 Sep; 335():79-84. PubMed ID: 26169827
[TBL] [Abstract][Full Text] [Related]
14. A high content imaging assay for identification of Botulinum neurotoxin inhibitors.
Kota KP; Soloveva V; Wanner LM; Gomba G; Kiris E; Panchal RG; Kane CD; Bavari S
J Vis Exp; 2014 Nov; (93):e51915. PubMed ID: 25489815
[TBL] [Abstract][Full Text] [Related]
15. Pre- and Post-synaptic Effects of Botulinum Toxin A on Submandibular Glands.
Xu H; Shan XF; Cong X; Yang NY; Wu LL; Yu GY; Zhang Y; Cai ZG
J Dent Res; 2015 Oct; 94(10):1454-62. PubMed ID: 26078423
[TBL] [Abstract][Full Text] [Related]
16. A dileucine in the protease of botulinum toxin A underlies its long-lived neuroparalysis: transfer of longevity to a novel potential therapeutic.
Wang J; Zurawski TH; Meng J; Lawrence G; Olango WM; Finn DP; Wheeler L; Dolly JO
J Biol Chem; 2011 Feb; 286(8):6375-85. PubMed ID: 21138836
[TBL] [Abstract][Full Text] [Related]
17. Neutralizing antibodies of botulinum neurotoxin serotype A screened from a fully synthetic human antibody phage display library.
Yu R; Wang S; Yu YZ; Du WS; Yang F; Yu WY; Sun ZW
J Biomol Screen; 2009 Sep; 14(8):991-8. PubMed ID: 19726786
[TBL] [Abstract][Full Text] [Related]
18. The role of the synaptic protein snap-25 in the potency of botulinum neurotoxin type A.
Keller JE; Neale EA
J Biol Chem; 2001 Apr; 276(16):13476-82. PubMed ID: 11278807
[TBL] [Abstract][Full Text] [Related]
19. Microarray analysis of differentially regulated genes in human neuronal and epithelial cell lines upon exposure to type A botulinum neurotoxin.
Thirunavukkarasusx N; Ghosal KJ; Kukreja R; Zhou Y; Dombkowski A; Cai S; Singh BR
Biochem Biophys Res Commun; 2011 Feb; 405(4):684-90. PubMed ID: 21291863
[TBL] [Abstract][Full Text] [Related]
20. Alpha-latrotoxin rescues SNAP-25 from BoNT/A-mediated proteolysis in embryonic stem cell-derived neurons.
Mesngon M; McNutt P
Toxins (Basel); 2011 May; 3(5):489-503. PubMed ID: 22069721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
